Suppression of CD3/CD28 antibody stimulated responses by human granulocytic myeloid-derived suppressor cells: Fact or artefact?

Immunology Letters

Volumn 152, Issue 2, 2013, Pages 151-152

  Hock, Barry D ^a   McKenzie, Judith L ^a  

^a CHRISTCHURCH HOSPITAL   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

CD28 ANTIBODY; CD3 ANTIBODY; CELL ANTIBODY; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG; CD28 ANTIGEN; CD3 ANTIGEN;

ANTIBODY RESPONSE; ANTIBODY STRUCTURE; BONE MARROW CELL; CANCER IMMUNOLOGY; CELLULAR IMMUNITY; CHEMICAL MODIFICATION; GRANULOCYTE; HUMAN; IMMUNE DEFICIENCY; IMMUNOMODULATION; LETTER; MYELOID DERIVED SUPPRESSOR CELL; OXIDATIVE STRESS; PHAGOCYTOSIS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SUPPRESSOR CELL; T LYMPHOCYTE; ANTIBODY PRODUCTION; IMMUNOLOGY; LYMPHOCYTE ACTIVATION;

ANTIBODY FORMATION; ANTIGENS, CD28; ANTIGENS, CD3; GRANULOCYTES; HUMANS; LYMPHOCYTE ACTIVATION; MYELOID CELLS; T-LYMPHOCYTES;

EID: 84879540984     PISSN: 01652478     EISSN: 18790542     Source Type: Journal    
DOI: 10.1016/j.imlet.2013.05.009     Document Type: Letter

References (9)

1. Gabrilovich D.I., Nagaraj S. Myeloid-derived suppressor cells as regulators of the immune system. Nat Rev Immunol 2009, 9:162-174.
2. Dumitru C.A., Moses K., Trellakis S., Lang S., Brandau S. Neutrophils and granulocytic myeloid-derived suppressor cells: immunophenotyping, cell biology and clinical relevance in human oncology. Cancer Immunol Immunother 2012, 61:1155-1167.
3. Dimitrov J.D., Vassilev T.L., Andre S., Kaveri S.V., Lacroix-Desmazes S. Functional variability of antibodies upon oxidative processes. Autoimmun Rev 2008, 7:574-578.
4. Naskalski J.W. Oxidative modification of protein structures under the action of myeloperoxidase and the hydrogen peroxide and chloride system. Ann Biol Clin (Paris) 1994, 52:451-456.
5. Uesugi M., Yoshida K., Jasin H.E. Inflammatory properties of IgG modified by oxygen radicals and peroxynitrite. J Immunol 2000, 165:6532-6537.
6. Cettour-Rose P., Nguyen T.X., Serrander L., Kaufmann M.T., Dayer J.M., Burger D., et al. T cell contact-mediated activation of respiratory burst in human polymorphonuclear leukocytes is inhibited by high-density lipoproteins and involves CD18. J Leukoc Biol 2005, 77:52-58.
7. Zlabinger G.J., Rosenkranz A.R., Schmaldienst S., Stuhlmeier K., Bohmig G., Stockl J., et al. Reactive oxygen product formation after Fc gamma receptor-mediated neutrophil activation by monomeric mouse IgG2a: implications for the generation of first dose effects after OKT3 treatment. Eur J Immunol 1993, 23:977-980.
8. Hock B.D., Taylor K.G., Cross N.B., Kettle A.J., Hampton M.B., McKenzie J.L. Effect of activated human polymorphonuclear leucocytes on T lymphocyte proliferation and viability. Immunology 2012, 137:249-258.
9. Neurauter A.A., Bonyhadi M., Lien E., Nokleby L., Ruud E., Camacho S., et al. Cell isolation and expansion using dynabeads. Adv Biochem Eng Biotechnol 2007, 106:41-73.